Skip to content

Doxorubicin-Postbiotic Transethosomes: Formulation and In Vitro Evaluation

Aug 2026 · Journal of Pharmaceutical Innovation · Vol 22 · 0 citations · 70 references

TL;DR

The developed transethosomal system showed favorable physicochemical properties, sustained drug release, stability, antioxidant and antimicrobial activity, and significant cytotoxicity against melanoma cells, which support its potential as a multifunctional topical platform for localized melanoma therapy and provide a basis for future in vivo evaluation.

View source

Similar papers

Sep 2026

Targeted Colorectal Cancer Therapy Using Cabozantinib-Loaded PLGA Nanoparticles: Formulation, Cytotoxicity, and Molecular Docking Analysis.

The present study represents improved Cabozantinib delivery via Cabozantinib-loaded poly(lactic-co-glycolic acid) nanoparticles, prepared by solvent evaporation. Nanoparticles had a size of 249.5 ± 12.9 nm, a polydispersity index of 0.18, a zeta potential of +2.61 mV, and an encapsulation efficiency of 19% w/w, reflect...

Aryan Thakkar, Sankha Bhattacharya, R. Shinde · 0 citations
Open access Sep 2026

Design, Development, and Characterization of Luliconazole-loaded Bilosomal Gel for Enhanced Cutaneous Delivery

Luliconazole (LZ) is a broad-spectrum antifungal agent whose topical performance is limited by poor aqueous solubility and restricted skin penetration. This study aimed to develop and characterise LZ-loaded bilosomes incorporated into a topical gel to enhance cutaneous delivery. Eight bilosomal formulations were prepar...

D. Prashar, Sarbjot Singh, Anita Devi et al. · 0 citations
Sep 2026

Hydroxyurea-Loaded Nanostructured Lipid Carriers for Enhanced In Vitro Cytotoxicity and Drug Delivery.

Hydroxyurea (HU) is an established anticancer drug used to treat chronic myelogenous leukemia, but its therapeutic efficacy is limited by rapid clearance, variable bioavailability, and dose-related toxicity. This study aimed to improve HU delivery by developing hydroxyurea-loaded nanostructured lipid carriers (NLCs) us...

O. Madkhali, Mohammad Intakhab Alam, Syam Mohan et al. · 0 citations
Sep 2026

PLGA nanoparticles co-loaded with resveratrol and doxycycline for dual-action periodontal therapy: in vitro and in vivo evaluation.

Periodontitis is a chronic inflammatory disease caused by a dysbiotic subgingival biofilm that triggers an imbalanced host immune response. This study developed and evaluated poly(lactic-co-glycolic acid) (PLGA) nanoparticles co-loaded with doxycycline (DOX) and resveratrol (RV) for dual-action periodontal therapy. Nan...

S. Alavi, Reza Boshrouyeh, Saeideh Sadeghi Neshat et al. · 0 citations
Aug 2026

Nano-liposomal encapsulation of isorhamnetin to enhance bioavailability and anticancer efficacy.

This study aimed to improve the bioavailability and anticancer efficacy of isorhamnetin (Iso), a flavonoid with poor water solubility, by encapsulating it into nanoliposomes and evaluating their effects. Iso-loaded nanoliposomes (Iso.NLP) were prepared via thin-film hydration and characterised for particle size, morpho...

Forough Parandak, S. Pourseyedi, Azadeh Lohrasbi-Nejad et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.